61 results
S-1/A
EX-4.5
FENC
Fennec Pharmaceuticals Inc
9 Feb 11
IPO registration (amended)
12:00am
institution (bank, stock broker, savings & loan association or credit union) with membership in an approved signature guarantee medallion program … Program (MSP) for Canadian holders, or (ii) by an eligible guarantor institution (bank, stock broker, savings & loan association or credit union
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
6 Jun 23
Other Events
5:39pm
of Hearing Loss in Pediatric Oncology Patients
~ Pedmarqsi™ is the First and Only Approved Therapy in the European Union for Reducing the Risk … for the reduction of cisplatin-induced hearing loss in pediatric patients.
The marketing authorization is applicable to all 27 European Union member
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
4 Apr 23
Other Events
12:32pm
in Pediatric Oncology Patients
~ First Therapy Recommended for Approval in the European Union for Reducing the Risk of Cisplatin-induced Hearing Loss … , solid tumors. When formally approved by the European Commission, Pedmarqsi will be the first and only treatment approved in the European Union (EU
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
in the European Union and U.K. for reducing the risk of cisplatin-induced hearing loss in pediatric patients with localized, non-metastatic solid tumors
Fennec
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
certain member states of the European Union); provided that if the Euro ceases to exist then the currency adopted by the Netherlands shall replace Euro … , terrorist financing or the proceeds of criminal activity, including, without limitation, (i) the European Union Anti-Money Laundering Directives
424B7
wm4uq7qu qtj
15 Mar 24
Prospectus with selling stockholder info
3:53pm
S-1/A
EX-4.6
maf iggsbfyy25da
9 Feb 11
IPO registration (amended)
12:00am
20FR12B
EX-4.7
n7yjfh0xhr
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am
10-K/A
inh11
7 Feb 11
Annual report (amended)
12:00am
20FR12B
EX-4.6
ofsomfl5s42zk0nhzhb3
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am